BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 19248584)

  • 1. [Src kinases in the process of maturation megakryocyte progenitors].
    Kamińska J; Klimczak-Jajor E; Bany-Łaszewicz U
    Postepy Biochem; 2008; 54(4):378-83. PubMed ID: 19248584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of inhibitor of Src kinases, SU6656, on differentiation of megakaryocytic progenitors and activity of alpha1,6-fucosyltransferase.
    Kaminska J; Klimczak-Jajor E; Skierski J; Bany-Laszewicz U
    Acta Biochim Pol; 2008; 55(3):499-506. PubMed ID: 18854874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and activation of Src family kinases in primary megakaryocytes.
    Lannutti BJ; Shim MH; Blake N; Reems JA; Drachman JG
    Exp Hematol; 2003 Dec; 31(12):1268-74. PubMed ID: 14662334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel strategy for generating platelet-like fragments from megakaryocytic cell lines and human progenitor cells.
    Gandhi MJ; Drachman JG; Reems JA; Thorning D; Lannutti BJ
    Blood Cells Mol Dis; 2005; 35(1):70-3. PubMed ID: 15923131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased megakaryocytopoiesis in Lyn-deficient mice.
    Lannutti BJ; Minear J; Blake N; Drachman JG
    Oncogene; 2006 Jun; 25(23):3316-24. PubMed ID: 16418722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous inhibition of Src and Aurora kinases by SU6656 induces therapeutic synergy in human synovial sarcoma growth, invasion and angiogenesis in vivo.
    Arai R; Tsuda M; Watanabe T; Ose T; Obuse C; Maenaka K; Minami A; Ohba Y
    Eur J Cancer; 2012 Oct; 48(15):2417-30. PubMed ID: 22244830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B cell proliferation following CD40 stimulation results in the expression and activation of Src protein tyrosine kinase.
    Néron S; Suck G; Ma XZ; Sakac D; Roy A; Katsman Y; Dussault N; Racine C; Branch DR
    Int Immunol; 2006 Feb; 18(2):375-87. PubMed ID: 16415104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects on cell motility, embryonic stem cell self-renewal and senescence by diverse Src kinase family inhibitors.
    Tamm C; Galitó SP; Annerén C
    Exp Cell Res; 2012 Feb; 318(4):336-49. PubMed ID: 22197704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of polyploidization in leukemic cell lines and primary bone marrow by Src kinase inhibitor SU6656.
    Lannutti BJ; Blake N; Gandhi MJ; Reems JA; Drachman JG
    Blood; 2005 May; 105(10):3875-8. PubMed ID: 15677565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Megakaryocyte development and platelet production.
    Deutsch VR; Tomer A
    Br J Haematol; 2006 Sep; 134(5):453-66. PubMed ID: 16856888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human B lymphocytes and non-Hodgkin's lymphoma cells become polyploid in response to the protein kinase inhibitor SU6656.
    Dussault N; Simard C; Néron S; Côté S
    Blood Cells Mol Dis; 2007; 39(1):130-4. PubMed ID: 17434768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developmental differences in megakaryocytopoiesis are associated with up-regulated TPO signaling through mTOR and elevated GATA-1 levels in neonatal megakaryocytes.
    Liu ZJ; Italiano J; Ferrer-Marin F; Gutti R; Bailey M; Poterjoy B; Rimsza L; Sola-Visner M
    Blood; 2011 Apr; 117(15):4106-17. PubMed ID: 21304100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Src activation triggers capacitation and acrosome reaction but not motility in human spermatozoa.
    Varano G; Lombardi A; Cantini G; Forti G; Baldi E; Luconi M
    Hum Reprod; 2008 Dec; 23(12):2652-62. PubMed ID: 18753142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression patterns of Src-family tyrosine kinases during Xenopus laevis development.
    Ferjentsik Z; Sindelka R; Jonak J
    Int J Dev Biol; 2009; 53(1):163-8. PubMed ID: 19123139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel N9-arenethenyl purines as potent dual Src/Abl tyrosine kinase inhibitors.
    Wang Y; Shakespeare WC; Huang WS; Sundaramoorthi R; Lentini S; Das S; Liu S; Banda G; Wen D; Zhu X; Xu Q; Keats J; Wang F; Wardwell S; Ning Y; Snodgrass JT; Broudy MI; Russian K; Dalgarno D; Clackson T; Sawyer TK
    Bioorg Med Chem Lett; 2008 Sep; 18(17):4907-12. PubMed ID: 18691885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sorafenib induces apoptosis specifically in cells expressing BCR/ABL by inhibiting its kinase activity to activate the intrinsic mitochondrial pathway.
    Kurosu T; Ohki M; Wu N; Kagechika H; Miura O
    Cancer Res; 2009 May; 69(9):3927-36. PubMed ID: 19366808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing megakaryocyte polyploidization by targeting multiple pathways of cytokinesis.
    Avanzi MP; Chen A; He W; Mitchell WB
    Transfusion; 2012 Nov; 52(11):2406-13. PubMed ID: 22612069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of Src family kinases in egg activation.
    Reut TM; Mattan L; Dafna T; Ruth KK; Ruth S
    Dev Biol; 2007 Dec; 312(1):77-89. PubMed ID: 17949706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dasatinib enhances megakaryocyte differentiation but inhibits platelet formation.
    Mazharian A; Ghevaert C; Zhang L; Massberg S; Watson SP
    Blood; 2011 May; 117(19):5198-206. PubMed ID: 21385851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 7-Alkoxy-4-phenylamino-3-quinolinecar-bonitriles as dual inhibitors of Src and Abl kinases.
    Boschelli DH; Wang YD; Johnson S; Wu B; Ye F; Barrios Sosa AC; Golas JM; Boschelli F
    J Med Chem; 2004 Mar; 47(7):1599-601. PubMed ID: 15027848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.